Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Vortioxetine is a multimodal antidepressant approved for the treatment of major depressive episodes. As part of the overall European risk-management plan, we aimed to fill data gaps on relevant missing information such as the extent of vortioxetine use in special populations and assessment of selected potential risks.
To investigate whether the use of SGLT‐2 inhibitors is associated with an increased risk of fractures. We conducted a cohort study with nested case‐control analysis based on the InGef database between November 2011 and December 2016 among patients with type 2 diabetes initiating treatment with or switching to or adding a new class of a non‐insulin antidiabetic drug.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
